SLC22A1
MOLECULAR TARGETsolute carrier family 22 member 1
SLC22A1 (solute carrier family 22 member 1) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SLC22A1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Clonidine | 1.61 | 4 |
| 2 | Procainamide | 1.39 | 3 |
| 3 | Quinidine | 1.39 | 3 |
| 4 | Cimetidine | 1.10 | 2 |
| 5 | ethopropazine | 1.10 | 2 |
| 6 | Phenformin | 0.69 | 1 |
| 7 | Progesterone | 0.69 | 1 |
| 8 | Carvedilol | 0.69 | 1 |
| 9 | Chlorhexidine | 0.69 | 1 |
| 10 | Corticosterone | 0.69 | 1 |
| 11 | Dextrorphan Dextro form of levorphanol. It acts as | 0.69 | 1 |
| 12 | Dinoprost | 0.69 | 1 |
| 13 | Dinoprostone | 0.69 | 1 |
| 14 | Guanabenz | 0.69 | 1 |
| 15 | Ipratropium | 0.69 | 1 |
| 16 | Levorphanol | 0.69 | 1 |
| 17 | Pindolol | 0.69 | 1 |
| 18 | Pramipexole | 0.69 | 1 |
About SLC22A1 as a Drug Target
SLC22A1 (solute carrier family 22 member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented SLC22A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SLC22A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.